Tuesday, December 08, 2009 10:51:44 AM
Shares of vaccine maker PharmAthene Inc. (PIP, $1.69, -$1.57, -48.16%) fell a day after the Department of Health and Human Services changed its approach in requesting anthrax vaccines. HHS canceled a request for proposals on recombinant protective antigen anthrax vaccine because it didn't believe vaccine developers submitting proposals could have product ready for licensure by the Food and Drug Administration within eight years.
Emergent BioSolutions Inc. (EBS, $12.52, -$1.88, -13.06%) also declined on the anthrax vaccine news, though it said the decision has no impact on its $400 million procurement contract with the Centers for Disease Control and Prevention for the delivery of 14.5 million doses of BioThrax--the only vaccine licensed by the FDA for the prevention of anthrax --into the Strategic National Stockpile.
Recent EBS News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:12:31 PM
- Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation • GlobeNewswire Inc. • 09/13/2024 10:45:00 AM
- Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola • GlobeNewswire Inc. • 09/12/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 11:47:30 AM
- Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile • GlobeNewswire Inc. • 09/03/2024 11:08:45 AM
- Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness • GlobeNewswire Inc. • 08/30/2024 12:16:09 PM
- Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions • GlobeNewswire Inc. • 08/29/2024 10:53:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:20:43 PM
- Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals • GlobeNewswire Inc. • 08/20/2024 03:30:55 PM
- Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa • GlobeNewswire Inc. • 08/19/2024 09:10:37 PM
- Emergent BioSolutions Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 09:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:34:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:21:53 PM
- Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country • GlobeNewswire Inc. • 08/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 12:56:36 PM
- Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million • GlobeNewswire Inc. • 07/31/2024 12:53:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:30:51 PM
- Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith • GlobeNewswire Inc. • 07/24/2024 11:30:00 AM
- Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024 • GlobeNewswire Inc. • 07/23/2024 12:27:06 PM
- Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in Canada • GlobeNewswire Inc. • 07/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:33:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:33:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 08:02:41 PM
- Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan • GlobeNewswire Inc. • 07/09/2024 11:30:04 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:57:07 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM